Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Formula makers shift away from BPA

This article was originally published in The Tan Sheet

Executive Summary

Manufacturers of liquid infant formula are seeking alternatives to bisphenol A to use in can linings, with FDA's blessing. CFSAN Director Stephen Sundlof says at the Science Board meeting Feb. 22, "They've come to the decision that rather than spending their time trying to reformulate a BPA-based epoxy, that they really need ... new alternatives. And having seen the research, we tend to agree with them." The agency in January said it has some concern about BPA's effects on fetuses, infants and children (1"The Tan Sheet" Jan. 25, 2010). CFSAN soon will post the results of its BPA studies for public comment

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel